Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1954 4
1957 1
1958 2
1959 3
1960 2
1961 2
1962 3
1963 5
1964 13
1965 7
1966 12
1967 7
1968 10
1969 8
1970 11
1971 22
1972 15
1973 12
1974 19
1975 20
1976 18
1977 20
1978 34
1979 23
1980 28
1981 22
1982 19
1983 22
1984 16
1985 13
1986 23
1987 17
1988 23
1989 23
1990 24
1991 24
1992 11
1993 9
1994 7
1995 20
1996 16
1997 22
1998 14
1999 9
2000 19
2001 32
2002 28
2003 8
2004 22
2005 18
2006 16
2007 16
2008 18
2009 9
2010 14
2011 10
2012 16
2013 10
2014 10
2015 18
2016 15
2017 14
2018 20
2019 14
2020 25
2021 34
2022 30
2023 27
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

1,071 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. Among authors: kozlov v. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.
Grünwald V, Powles T, Kopyltsov E, Kozlov V, Alonso-Gordoa T, Eto M, Hutson T, Motzer R, Winquist E, Maroto P, Keam B, Procopio G, Wong S, Melichar B, Rolland F, Oya M, Rodriguez-Lopez K, Saito K, McKenzie J, Porta C. Grünwald V, et al. Among authors: kozlov v. Eur Urol Oncol. 2023 Aug;6(4):437-446. doi: 10.1016/j.euo.2023.01.010. Epub 2023 Jan 29. Eur Urol Oncol. 2023. PMID: 36720658 Free PMC article. Clinical Trial.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. Among authors: kozlov v. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.
Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis.
Morozov A, Taratkin M, Shpikina A, Ehrlich Y, McFarland J, Dymov A, Kozlov V, Fajkovic H, Rivas JG, Lusuardi L, Teoh JY, Herrmann T, Baniel J, Enikeev D. Morozov A, et al. Among authors: kozlov v. World J Urol. 2023 Dec;41(12):3471-3483. doi: 10.1007/s00345-023-04666-8. Epub 2023 Nov 18. World J Urol. 2023. PMID: 37980297 Review.
New Insight into the Role of AhR in Lung Carcinogenesis.
Akhmetova DA, Kozlov VV, Gulyaeva LF. Akhmetova DA, et al. Among authors: kozlov vv. Biochemistry (Mosc). 2022 Nov;87(11):1219-1225. doi: 10.1134/S0006297922110013. Biochemistry (Mosc). 2022. PMID: 36509717 Free article. Review.
A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D; Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology. Morozov A, et al. Among authors: kozlov v. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):681-692. doi: 10.1038/s41391-023-00673-3. Epub 2023 Apr 25. Prostate Cancer Prostatic Dis. 2023. PMID: 37185992 Review.
Nafion: New and Old Insights into Structure and Function.
Ninham BW, Battye MJ, Bolotskova PN, Gerasimov RY, Kozlov VA, Bunkin NF. Ninham BW, et al. Among authors: kozlov va. Polymers (Basel). 2023 May 7;15(9):2214. doi: 10.3390/polym15092214. Polymers (Basel). 2023. PMID: 37177360 Free PMC article. Review.
1,071 results